Transfusion volumes associated with TXA+ use
| Parameter estimate (SD) | P value | |
| During index surgery | ||
| TXA+ (ortho/spine case) | 0.95 (0.16) | <0.01 |
| Proximal fracture site | 0.01 (0.17) | 0.96 |
| Damage control surgery (admission) | 0.07 (0.31) | 0.81 |
| Tourniquet use index case | 0.07 (0.22) | 0.74 |
| Total number of surgeries/admission | 0.29 (0.08) | <0.01 |
| Cumulative admission | ||
| TXA+ (ortho/spine case) | 1.23 (0.40) | <0.01 |
| Proximal fracture site | −0.39 (0.43) | 0.36 |
| Damage control surgery (admission) | 2.47 (0.78) | <0.01 |
| Tourniquet use index case | −0.97 (0.56) | 0.08 |
| Total number of surgeries/admission | 2.92 (0.78) | <0.01 |
TXA, tranexamic acid.